TCL Archive In Brief: Waldmann, Fisher Win Top Miken Prizes Of $250,000 Each, Six Others Get $50,000 November 10, 1989
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Pepper Committee, Impressed By Progress Reports, Promises Help With NCI Funding June 29, 1979
TCL Archive Piedmont, Mid-Atlantic Organizations Win Competition for NCI Support Of New Regional Cooperative Groups April 16, 1982
